The role of proximal and distal sequenced variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV

Virology

Volumn 236, Issue 2, 1997, Pages 221-233

  Kim, Victor ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CLONE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ECOTROPIC VIRUS; EPITOPE MAPPING; GENETIC VARIABILITY; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0030775536     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8747     Document Type: Article

References (65)

1. Bergmann C. C., Tong L., Cua R., Sensintaffar J., Stohlman S. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:1994;5306-5310.
2. Bergmann C. C., Yao Q., Ho C., Buckwold S. L. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157:1996;3242-3249.
3. Boral A. L., Okenquist S. A., Lenz J. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell specific element. J. Virol. 63:1989;76-84.
4. Chattopadhyay S. K., Lander M. R., Gupta S., Rands E., Lowy D. R. Origin of mink cytopathic focus-forming (MCF) viruses: Comparison with ecotropic and xenotropic murine leukemia virus genomes. Virology. 113:1981;465-483.
5. Chimini G., Pala P., Sire J., Jordan B. R., Maryanski J. L. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:1989;297-302.
6. Cloyd M. W., Thompson M. M., Hartley J. W. Host range of mink cell focus-inducing viruses. Virology. 140:1985;239-248.
7. b. Virology. 202:1994;500-505.
8. Coppola M. A., Green W. R., Rich R. F. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV. Viral Immunol. 9:1996;107-119.
9. Coppola M. A., Lam T. M., Strawbridge R. R., Green W. R. Recognition of endogenous ecotropic murine leukaemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes (CTL): Epitope variation in a CTL-resistant virus. J. Gen. Virol. 76:1995;635-641.
10. Couillin I., Culmann-Penciolelli B., Gomard E., Choppin J., Levy J., Guillet J., Saragosti S. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1994;1129-1134.
11. Dai H. Y., Etzerodt M., Baekgaard A. J., Lovmand S., Jorgensen P., Kjeldgaard N. O., Pedersen F. S. Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology. 175:1990;581-585.
12. Davidson I., Xiao, Jia H., Rosales R., Staub A., Chambon P. The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequece. Cell. 54:1988;931-942.
13. Del Val M., Schlicht H., Ruppert T., Reddehase M. J., Koszinowski U. H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell. 66:1991;1145-1153.
14. DesGroseillers L., Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:1984;945-952.
15. Eggers M., Boes-Fabian B., Ruppert T., Kloetzel P., Koszinowski U. H. The clevage preference of the proteasome governs the yeild of antigenic peptides. J. Exp. Med. 182:1995;1865-1870.
16. Eisenlohr L. C., Yewdell J. W., Bennink J. R. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:1992;481-487.
17. Elder J. H., Gautsch J. W, Jensen F. C., Lerner R. A., Hartley J. W., Rowe W. P. Biochemical evidence that MCF murine leukemia viruses are envelope (env. Proc. Natl. Acad. Sci. USA. 74:1977;4676-4680.
18. Fu T., Bonneau R. H., Tevethia M. J., Tevethia S. S. Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes. J. Virol. 67:1993;6866-6871.
19. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120:1978;2027-2032.
20. Graves B. J., Eisenman R. N., McKnight S. L. Delineation of transcriptional control signals within the moloney murine sarcoma virus long terminal repeat. Mol. Cell. Biol. 5:1985;1948-1958.
21. Green W. R. H-2 restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous murine leukemia virus-induced tumors: Correlation of tumor cell susceptibility with expression of the gross cell surface antigen. J. Immunol. 125:1980;2584-2590.
22. Green W. R. Thein vitro. J. Immunol. 128:1982;1043-1049.
23. Green W. R. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. J. Immunol. 132:1984;2658-2664.
24. Green W. R., Graziano R. F. Cytolytic T lymphocyte-defined retroviral antigens on normal cells: Encoding by theAkv-1. Immunogenetics. 23:1986;106-110.
25. Green W. R., Smith P. M. Endogenous ecotropic and recombinant MCF mouse retroviral variation and escape from antiviral CTL. Semin. Virol. 7:1996;49-60.
26. Green W. R., Nowinski R. C., Henney C. S. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J. Exp. Med. 150:1979;51-66.
27. Hahn Y. S., Braciale V. L., Braciale T. J. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:1991;733-736.
28. +. J. Exp. Med. 176:1992;1335-1341.
29. Hallberg B., Grundstrom T. Tissue specific sequence motifs in the enhancer of the leukaemongenic mouse retrovirus SL3-3. Nucleic Acids Res. 16:1988;5927-5944.
30. Hartley J. W., Wolford N. K., Old L. J., Rowe W. P. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. USA. 74:1977;789-792.
31. Herr W. Nucleotide sequence of AKV murine leukemia virus. J. Virol. 49:1984;471-478.
32. Kelly M., Holland C. A., Lung M., Chattopadhyay, Lowy D. R., Hopkins N. H. Nucleotide sequence of the 3′ end of MCF 247 murine leukemia virus. J. Virol. 45:1983;291-298.
33. Khan A. S. Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses. J. Virol. 50:1984;864-871.
34. Koup R. A. Virus escape from CTL recognition. J. Exp. Med. 180:1994;779-782.
35. J. Lenz.
36. LoSardo J. E., Cupelli L. A., Short M. K., Berman J. W., Lenz J. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells. J. Virol. 63:1989;1087-1094.
37. Lostrom M. E., Stone M. R., Tam M., Burnette W. N., Pinter A., Nowinski R. C. Monoclonal antibodies against murine leukemia viruses: Identification of six antigenic determinants on the p15(E) and gp70 envelope proteins. Virology. 98:1979;336-350.
38. Lovmand S., Kjeldgaard N. O., Jorgensen P., Pedersen F. S. Enhancer functions in U3 of Akv virus: A role for cooperativity for a tandem direct repeat unit and its flanking DNA sequences. J. Virol. 64:1990;3185-3191.
39. Moore M. W., Carbone F. R., Bevan M. J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:1988;777-785.
40. Morrison H. L., Soni B., Lenz J. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc. J. Virol. 69:1995;446-455.
41. b. J. Virol. 69:1995;6665-6677.
42. Neisig A., Roelse J., Sijts A., Ossendorp F., Feltkamp M., Kast M., Melief C., Neefjes J. J. Major differences in transporter associated with antigen presentation [TAP]-dependent translocation of MHC class I presentable peptides and the effect of flanking sequences. J. Immunol. 154:1995;1273-1279.
43. Niedermann G., Butz S., Ihlenfeldt H., Grimm R., Lucchiari M., Hoschutzky H., Jung G., Maier B., Eichmann K. Contribution of proteasome-mediated hydolysis to the hierarchy of epitopes presented by major histocompatibility complex class I moleules. Immunity. 2:1995;289-299.
44. Ossendorp F., Eggers M., Neisig A., Ruppert T., Groettrup M., Sijts A., Mengede E., Kloetzel P., Neefjes J., Koszinowski U., Melief C. A single residue exchange within a viral CTL epitope alters proteasome-mediated degredation resulting in a lack of antigen presentation. Immunity. 5:1996;115-124.
45. Ozato K., Sachs D. H. Monoclonal antibodies to mouse MHC antigens. J. Immunol. 126:1981;317-321.
46. Pinter A., Honnen W. J., Tung J. S., O'Donnell P. V., Hammerling U. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology. 116:1982;499-516.
47. Portis J. L., McAtee F. J., Cloyd M. W. Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during the graft-versus-host reaction. Virology. 118:1982;181-190.
48. Rammensee H. G., Falk K., Rotzschke O. Annu. Rev. Immunol. 11:1993;213-244.
49. Rammensee H. G., Friede T., Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-228.
50. Rich R. F., Green W. R. Genetic control of CTL responses to AKR/Gross virus: effect of inheritance of Akv proviruses. Immunogenetics. 27:1988;304-312.
51. Rock K. L., Rothstein L., Gamble S. Generation of class I MHC-restricted T-T hybridomas. J. Immunol. 145:1990;804-811.
52. Shastri N., Serwold T., Gonzalez F. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:1995;4339-4346.
53. Sijts A., Ossendorp F., Mengede E., Elsen P., Melief C. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J. Immunol. 152:1994;106-116.
54. Speck N. A., Baltimore D. Six distinct nuclear factors interact with the 75 base pair repeat of the moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1987;1101-1110.
55. Speck N. A., Renjifo B., Golemis E., Fredrickson T. N., Hartley J. W., Hopkins N. Mutation of the core or adjacent LVb elements of the moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:1990;233-242.
56. Steffen D. L., Taylor B. A., Weinberg R. A. Continuing germ line integration of AKV proviruses during the breeding of AKR mice and derivative recombinant inbred strains. J. Virol. 42:1982;165-175.
57. Stoye J. P., Moroni C., Coffin J. M. Virological events leading to spontaneous AKR thymomas. J. Virol. 65:1991;1273-1285.
58. Thomas C. Y., Nuckols J. D., Murphy C., Innes D. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus. Virology. 193:1993;1013-1017.
59. White H. D., Green W. R., Gine N. R. Molecular cloning of infectious ecotropic murine leukemia virus AK7 from anemv. J. Virol. 67:1993;5045-5050.
60. White H. D., Robbins M. D., Green W. R. Mechanism of escape of endogenous murine leukemia virusemv. J. Virol. 64:1990;2608-2619.
61. b. J. Virol. 68:1994a;897-904.
62. b. Viral Immunol. 7:1994b;51-59.
63. Yellen-Shaw A. J., Eisenlohr L. C. Regulation of class I restricted epitope processing by local or distal flanking sequence. J. Immunol. 158:1997a;1727-1733.
64. Yellen-Shaw A. J., Wherry E. J., Dubois G. C., Eisenlohr L. C. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full length viral protein. J. Immunol. 158:1997b;3227-3234.
65. Yewdell J. W., Anton L. C., Bennink J. R. Defective ribosomal products (DRiPs): A major source of antigenic peptides for MHC class I molecules? J. Immunol. 157:1996;1823-1826.